1 Min Read
Jan 5 (Reuters) - Chimerix Inc:
* CHIMERIX INITIATES ADAPT STUDY FOR ORAL BRINCIDOFOVIR AND ADVANCES IV BRINCIDOFOVIR TO PATIENT STUDIES Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.